Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 575,472 shares at $27.27 ($15.7M) on 2022-11-11, disclosed to the SEC on 2022-11-14.
Open-market sale of $15.7M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.21 | 5,269 | $143K | 0.9% |
| 2 | $27.21 | 5,269 | $143K | 0.9% |
| 3 | $27.35 | 123,113 | $3.4M | 21.4% |
| 4 | $27.35 | 123,113 | $3.4M | 21.4% |
| 5 | $27.27 | 159,354 | $4.3M | 27.7% |
| 6 | $27.27 | 159,354 |
| $4.3M |
| 27.7% |
| Total | $27.30 avg | 575,472 | $15.7M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |